MabCure Inc
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, In… Read more
MabCure Inc (MBCI) - Net Assets
Latest net assets as of December 2011: $3.88 Million USD
Based on the latest financial reports, MabCure Inc (MBCI) has net assets worth $3.88 Million USD as of December 2011.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.81 Million) and total liabilities ($935.15K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.88 Million |
| % of Total Assets | 80.56% |
| Annual Growth Rate | -41.37% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 31.22 |
MabCure Inc - Net Assets Trend (2008–2011)
This chart illustrates how MabCure Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MabCure Inc (2008–2011)
The table below shows the annual net assets of MabCure Inc from 2008 to 2011.
| Year | Net Assets | Change |
|---|---|---|
| 2011-12-31 | $3.88 Million | -75.35% |
| 2010-12-31 | $15.72 Million | -13.14% |
| 2009-12-31 | $18.10 Million | -5.74% |
| 2008-12-31 | $19.21 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to MabCure Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1550396000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2011)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $64.02K | 1.65% |
| Other Comprehensive Income | $-33.40K | -0.86% |
| Other Components | $19.35 Million | 499.31% |
| Total Equity | $3.88 Million | 100.00% |
MabCure Inc Competitors by Market Cap
The table below lists competitors of MabCure Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Interplay Entertainment Corp
PINK:IPLY
|
$0.98 |
|
Urologix Inc
PINK:ULGX
|
$0.98 |
|
Velocity Energy Inc
PINK:VCYE
|
$0.98 |
|
Patient Portal Technologies Inc
PINK:PPRG
|
$0.98 |
|
Pacific Conquest Holdings Inc
PINK:PCHK
|
$0.98 |
|
Andatee China Marine Fuel Services
PINK:AMCF
|
$0.98 |
|
CTPartners Executive Search Inc
PINK:CTPR
|
$0.98 |
|
Next.e.GO N.V. Ordinary Shares
NASDAQ:EGOX
|
$0.98 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MabCure Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2010 to 2011, total equity changed from 15,724,959 to 3,876,037, a change of -11,848,922 (-75.4%).
- Net loss of 12,451,496 reduced equity.
- Share repurchases of 15,786 reduced equity.
- Other comprehensive income decreased equity by 1,581.
- Other factors increased equity by 619,941.
Equity Change Factors (2010 to 2011)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-12.45 Million | -321.24% |
| Share Repurchases | $15.79K | -0.41% |
| Other Comprehensive Income | $-1.58K | -0.04% |
| Other Changes | $619.94K | +15.99% |
| Total Change | $- | -75.35% |
Book Value vs Market Value Analysis
This analysis compares MabCure Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | $0.01 | $0.00 | x |
| 2007-12-31 | $0.00 | $0.00 | x |
| 2008-12-31 | $0.45 | $0.00 | x |
| 2009-12-31 | $0.30 | $0.00 | x |
| 2010-12-31 | $0.25 | $0.00 | x |
| 2011-12-31 | $0.06 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MabCure Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -321.24%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2490.30%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 1.24x
- Recent ROE (-321.24%) is below the historical average (-58.11%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | -7.84% | 0.00% | 0.00x | 1.00x | $-9.10K |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-101.34K |
| 2008 | -2.77% | 0.00% | 0.00x | 1.01x | $-2.45 Million |
| 2009 | -7.67% | 0.00% | 0.00x | 1.05x | $-3.20 Million |
| 2010 | -9.11% | 0.00% | 0.00x | 1.03x | $-3.01 Million |
| 2011 | -321.24% | -2490.30% | 0.10x | 1.24x | $-12.84 Million |
Industry Comparison
This section compares MabCure Inc's net assets metrics with peer companies in the Solar industry.
Industry Context
- Industry: Solar
- Average net assets among peers: $424,642,617
- Average return on equity (ROE) among peers: 1.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MabCure Inc (MBCI) | $3.88 Million | -7.84% | 0.24x | $0.98 |
| ABCO Energy Inc (ABCE) | $-190.65K | 0.00% | 0.00x | $11.90K |
| Advantagewon Oil Corporation (ANTGF) | $-1.30 Million | 0.00% | 0.00x | $547.13K |
| Advanced Powerline Technologies Inc (APWL) | $6.31 Million | -45.47% | 0.40x | $1.82 |
| Array Technologies Inc (ARRY) | $-25.72 Million | 0.00% | 0.00x | $972.65 Million |
| Ascent Solar Technologies, Inc. Common Stock (ASTI) | $139.62 Million | -9.47% | 0.10x | $18.06 Million |
| Beam Global (BEEM) | $-1.41 Million | 0.00% | 0.00x | $26.89 Million |
| Clear Blue Technologies International Inc (CBUTF) | $-215.24K | 0.00% | 0.00x | $834.08K |
| China Changjiang Mining & New Energy Co Ltd (CHJI) | $924.23K | 64.84% | 0.83x | $2.91K |
| Canadian Solar Inc (CSIQ) | $4.15 Billion | 0.87% | 2.26x | $868.69 Million |
| Complete Solaria, Inc. Common Stock (CSLR) | $-21.39 Million | 0.00% | 0.00x | $89.72 Million |